company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q1,2010-10-01,2010-12-31,2012-02-09 16:07:12+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1437682.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q1,2010-10-01,2010-12-31,2012-02-09 16:07:12+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1437682.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q1,2010-10-01,2010-12-31,2012-02-09 16:07:12+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,68761.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q1,2010-10-01,2010-12-31,2012-02-09 16:07:12+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-1047420.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q1,2010-10-01,2010-12-31,2012-02-09 16:07:12+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1537039.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q1,2010-10-01,2010-12-31,2012-02-09 16:07:12+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-879302.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q1,2010-10-01,2010-12-31,2012-02-09 16:07:12+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-879302.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q1,2010-10-01,2010-12-31,2012-02-09 16:07:12+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,43279.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q1,2010-10-01,2010-12-31,2012-02-09 16:07:12+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,43279.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q1,2010-10-01,2010-12-31,2012-02-09 16:07:12+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,43279.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q1,2010-10-01,2010-12-31,2012-02-09 16:07:12+00:00,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,-544335.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q1,2010-10-01,2010-12-31,2012-02-09 16:07:12+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1380358.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q2,2011-01-01,2011-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,2905237.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q2,2011-01-01,2011-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2905237.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q2,2011-01-01,2011-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,67809.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q2,2011-01-01,2011-03-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,15469.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q2,2011-01-01,2011-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-3948330.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q2,2011-01-01,2011-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-3186898.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q2,2011-01-01,2011-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-4146713.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q2,2011-01-01,2011-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-4146713.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q2,2011-01-01,2011-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-5880.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q2,2011-01-01,2011-03-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-1700398.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q2,2011-01-01,2011-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,589696.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q2,2011-01-01,2011-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1116582.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q2,2011-01-01,2011-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1116582.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q2,2011-01-01,2011-03-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1719157.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q2,2011-01-01,2011-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1719157.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q2,2011-01-01,2011-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1719157.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q2,2011-01-01,2011-03-31,,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,2866933.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q2,2011-01-01,2011-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-677205.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q2,2011-01-01,2011-03-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,105000.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q2,2011-01-01,2011-03-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,742500.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q3,2011-04-01,2011-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1819917.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q3,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1819917.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q3,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,66471.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q3,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-27956.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q3,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,823484.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q3,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-9116.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q3,2011-04-01,2011-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-967034.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q3,2011-04-01,2011-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-967034.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q3,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-3794.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q3,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,540611.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q3,2011-04-01,2011-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,536817.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q3,2011-04-01,2011-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,536817.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q3,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-1705273.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q3,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1719158.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q3,2011-04-01,2011-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,13885.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q3,2011-04-01,2011-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,13885.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q3,2011-04-01,2011-06-30,,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,-56959.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q3,2011-04-01,2011-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-473291.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q3,2012-04-01,2012-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7991510.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q3,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7991510.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q3,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,423415.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q3,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-26918.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q3,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2534317.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q3,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1170848.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q3,2012-04-01,2012-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-3889848.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q3,2012-04-01,2012-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-3889848.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q3,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-115559.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q3,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,18509.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q3,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,20998.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q3,2012-04-01,2012-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-76052.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q3,2012-04-01,2012-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-76052.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q3,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-52307.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q3,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,2705059.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q3,2012-04-01,2012-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2652752.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q3,2012-04-01,2012-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2652752.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q3,2012-04-01,2012-06-30,,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,677.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q3,2012-04-01,2012-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1312471.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q3,2012-04-01,2012-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,11905.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q1,2012-10-01,2012-12-31,2014-02-04 16:33:07+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4614159.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q1,2012-10-01,2012-12-31,2014-02-04 16:33:07+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4614159.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q1,2012-10-01,2012-12-31,2014-02-04 16:33:07+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,449597.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q1,2012-10-01,2012-12-31,2014-02-04 16:33:07+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,572.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q1,2012-10-01,2012-12-31,2014-02-04 16:33:07+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,274189.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q1,2012-10-01,2012-12-31,2014-02-04 16:33:07+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,52215.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q1,2012-10-01,2012-12-31,2014-02-04 16:33:07+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-3837586.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q1,2012-10-01,2012-12-31,2014-02-04 16:33:07+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-3837586.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q1,2012-10-01,2012-12-31,2014-02-04 16:33:07+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-9439.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q1,2012-10-01,2012-12-31,2014-02-04 16:33:07+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,0.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q1,2012-10-01,2012-12-31,2014-02-04 16:33:07+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,0.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q1,2012-10-01,2012-12-31,2014-02-04 16:33:07+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,121418.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q1,2012-10-01,2012-12-31,2014-02-04 16:33:07+00:00,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,0.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q1,2012-10-01,2012-12-31,2014-02-04 16:33:07+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,0.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q1,2012-10-01,2012-12-31,2014-02-04 16:33:07+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,0.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q1,2012-10-01,2012-12-31,2014-02-04 16:33:07+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,111979.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q1,2012-10-01,2012-12-31,2014-02-04 16:33:07+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,111979.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q1,2012-10-01,2012-12-31,2014-02-04 16:33:07+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-53098.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q1,2012-10-01,2012-12-31,2014-02-04 16:33:07+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,0.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q1,2012-10-01,2012-12-31,2014-02-04 16:33:07+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,3332467.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q1,2012-10-01,2012-12-31,2014-02-04 16:33:07+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,0.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q1,2012-10-01,2012-12-31,2014-02-04 16:33:07+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,3279369.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q1,2012-10-01,2012-12-31,2014-02-04 16:33:07+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3279369.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q1,2012-10-01,2012-12-31,2014-02-04 16:33:07+00:00,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,-18.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q1,2012-10-01,2012-12-31,2014-02-04 16:33:07+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-446256.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q1,2012-10-01,2012-12-31,2014-02-04 16:33:07+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,11114.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q1,2012-10-01,2012-12-31,2014-02-04 16:33:07+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,0.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q2,2013-01-01,2013-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6757936.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q2,2013-01-01,2013-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6757936.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q2,2013-01-01,2013-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,448765.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q2,2013-01-01,2013-03-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,36359.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q2,2013-01-01,2013-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1665788.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q2,2013-01-01,2013-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,140260.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q2,2013-01-01,2013-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-4466764.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q2,2013-01-01,2013-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-4466764.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q2,2013-01-01,2013-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-22029.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q2,2013-01-01,2013-03-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,8036.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q2,2013-01-01,2013-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1160181.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q2,2013-01-01,2013-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,1146188.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q2,2013-01-01,2013-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,1146188.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q2,2013-01-01,2013-03-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-53497.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q2,2013-01-01,2013-03-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,3756860.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q2,2013-01-01,2013-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,3703363.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q2,2013-01-01,2013-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3703363.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q2,2013-01-01,2013-03-31,,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,-336.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q2,2013-01-01,2013-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,382451.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q2,2013-01-01,2013-03-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,10714.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q1,2013-10-01,2013-12-31,2015-02-09 16:09:24+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10628312.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q1,2013-10-01,2013-12-31,2015-02-09 16:09:24+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10628312.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q1,2013-10-01,2013-12-31,2015-02-09 16:09:24+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,403405.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q1,2013-10-01,2013-12-31,2015-02-09 16:09:24+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,28443.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q1,2013-10-01,2013-12-31,2015-02-09 16:09:24+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,517280.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q1,2013-10-01,2013-12-31,2015-02-09 16:09:24+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2656852.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q1,2013-10-01,2013-12-31,2015-02-09 16:09:24+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-7022332.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q1,2013-10-01,2013-12-31,2015-02-09 16:09:24+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-7022332.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q1,2013-10-01,2013-12-31,2015-02-09 16:09:24+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-116215.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q1,2013-10-01,2013-12-31,2015-02-09 16:09:24+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-19075306.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q1,2013-10-01,2013-12-31,2015-02-09 16:09:24+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,0.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q1,2013-10-01,2013-12-31,2015-02-09 16:09:24+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,4045956.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q1,2013-10-01,2013-12-31,2015-02-09 16:09:24+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,0.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q1,2013-10-01,2013-12-31,2015-02-09 16:09:24+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-15145565.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q1,2013-10-01,2013-12-31,2015-02-09 16:09:24+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-15145565.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q1,2013-10-01,2013-12-31,2015-02-09 16:09:24+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,54715.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q1,2013-10-01,2013-12-31,2015-02-09 16:09:24+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,62821592.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q1,2013-10-01,2013-12-31,2015-02-09 16:09:24+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,0.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q1,2013-10-01,2013-12-31,2015-02-09 16:09:24+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,62766877.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q1,2013-10-01,2013-12-31,2015-02-09 16:09:24+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,62766877.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q1,2013-10-01,2013-12-31,2015-02-09 16:09:24+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,40598980.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q1,2013-10-01,2013-12-31,2015-02-09 16:09:24+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,9496.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q4,2014-07-01,2014-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-22430442.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q4,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-22430442.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q4,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,270417.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q4,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,377596.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q4,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4025485.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q4,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,6837138.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q4,2014-07-01,2014-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-10919806.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q4,2014-07-01,2014-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-10919806.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q4,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-465375.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q4,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,10000.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q4,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,5000296.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q4,2014-07-01,2014-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,4544921.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q4,2014-07-01,2014-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,4544921.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q4,2014-07-01,2014-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,535762.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q4,2014-07-01,2014-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,535762.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q4,2014-07-01,2014-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-5839123.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q4,2014-07-01,2014-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,4157.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q4,2014-07-01,2014-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,5862.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q1,2014-10-01,2014-12-31,2016-02-09 16:16:29+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-22575282.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q1,2014-10-01,2014-12-31,2016-02-09 16:16:29+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-22575282.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q1,2014-10-01,2014-12-31,2016-02-09 16:16:29+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,290039.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q1,2014-10-01,2014-12-31,2016-02-09 16:16:29+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,347703.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q1,2014-10-01,2014-12-31,2016-02-09 16:16:29+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2041237.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q1,2014-10-01,2014-12-31,2016-02-09 16:16:29+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-4303703.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q1,2014-10-01,2014-12-31,2016-02-09 16:16:29+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-24200006.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q1,2014-10-01,2014-12-31,2016-02-09 16:16:29+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-24200006.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q1,2014-10-01,2014-12-31,2016-02-09 16:16:29+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-7554945.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q1,2014-10-01,2014-12-31,2016-02-09 16:16:29+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,500.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q1,2014-10-01,2014-12-31,2016-02-09 16:16:29+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,3054774.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q1,2014-10-01,2014-12-31,2016-02-09 16:16:29+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-4499671.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q1,2014-10-01,2014-12-31,2016-02-09 16:16:29+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-4499671.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q1,2014-10-01,2014-12-31,2016-02-09 16:16:29+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-103168.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q1,2014-10-01,2014-12-31,2016-02-09 16:16:29+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,283466.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q1,2014-10-01,2014-12-31,2016-02-09 16:16:29+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,180298.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q1,2014-10-01,2014-12-31,2016-02-09 16:16:29+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,180298.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q1,2014-10-01,2014-12-31,2016-02-09 16:16:29+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-28519379.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q1,2014-10-01,2014-12-31,2016-02-09 16:16:29+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,3938.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q2,2015-01-01,2015-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-28686412.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q2,2015-01-01,2015-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-28686412.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q2,2015-01-01,2015-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,449559.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q2,2015-01-01,2015-03-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,320661.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q2,2015-01-01,2015-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,12302289.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q2,2015-01-01,2015-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-755675.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q2,2015-01-01,2015-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-16369578.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q2,2015-01-01,2015-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-16369578.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q2,2015-01-01,2015-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-297118.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q2,2015-01-01,2015-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,9096000.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q2,2015-01-01,2015-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,8798882.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q2,2015-01-01,2015-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,8798882.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q2,2015-01-01,2015-03-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-3386.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q2,2015-01-01,2015-03-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,30152.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q2,2015-01-01,2015-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,26766.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q2,2015-01-01,2015-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,26766.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q2,2015-01-01,2015-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-7543930.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q2,2015-01-01,2015-03-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,3717.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q2,2015-01-01,2015-03-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,2400.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q3,2015-04-01,2015-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-15936052.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q3,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-15936052.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q3,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,741058.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q3,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,276750.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q3,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2505269.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q3,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-704822.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q3,2015-04-01,2015-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-13117797.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q3,2015-04-01,2015-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-13117797.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q3,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-3283588.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q3,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,7260372.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q3,2015-04-01,2015-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,3976784.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q3,2015-04-01,2015-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,3976784.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q3,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-53608.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q3,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,133.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q3,2015-04-01,2015-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-53475.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q3,2015-04-01,2015-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-53475.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q3,2015-04-01,2015-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-9194488.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q3,2015-04-01,2015-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,3498.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q4,2015-07-01,2015-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-24743136.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q4,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-24743136.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q4,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,855551.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q4,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-945114.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q4,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4618217.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q4,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,8194248.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q4,2015-07-01,2015-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-12020234.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q4,2015-07-01,2015-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-12020234.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q4,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-834961.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q4,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,6679804.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q4,2015-07-01,2015-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,5844843.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q4,2015-07-01,2015-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,5844843.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q4,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-53829.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q4,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,190761.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q4,2015-07-01,2015-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,136932.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q4,2015-07-01,2015-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,136932.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q4,2015-07-01,2015-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-6038459.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q4,2015-07-01,2015-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,3276.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q1,2015-10-01,2015-12-31,2017-02-06 16:16:26+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-19264414.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q1,2015-10-01,2015-12-31,2017-02-06 16:16:26+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-19264414.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q1,2015-10-01,2015-12-31,2017-02-06 16:16:26+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,794349.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q1,2015-10-01,2015-12-31,2017-02-06 16:16:26+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,108403.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q1,2015-10-01,2015-12-31,2017-02-06 16:16:26+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2380343.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q1,2015-10-01,2015-12-31,2017-02-06 16:16:26+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-5166750.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q1,2015-10-01,2015-12-31,2017-02-06 16:16:26+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-21148069.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q1,2015-10-01,2015-12-31,2017-02-06 16:16:26+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-21148069.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q1,2015-10-01,2015-12-31,2017-02-06 16:16:26+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-406612.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q1,2015-10-01,2015-12-31,2017-02-06 16:16:26+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,3000000.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q1,2015-10-01,2015-12-31,2017-02-06 16:16:26+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,2593388.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q1,2015-10-01,2015-12-31,2017-02-06 16:16:26+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,2593388.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q1,2015-10-01,2015-12-31,2017-02-06 16:16:26+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-54051.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q1,2015-10-01,2015-12-31,2017-02-06 16:16:26+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-440534.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q1,2015-10-01,2015-12-31,2017-02-06 16:16:26+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-494585.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q1,2015-10-01,2015-12-31,2017-02-06 16:16:26+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-494585.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q1,2015-10-01,2015-12-31,2017-02-06 16:16:26+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-19049266.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q1,2015-10-01,2015-12-31,2017-02-06 16:16:26+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,3054.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q2,2016-01-01,2016-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-20815860.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q2,2016-01-01,2016-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-20815860.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q2,2016-01-01,2016-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,803912.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q2,2016-01-01,2016-03-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,71057.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q2,2016-01-01,2016-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2416839.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q2,2016-01-01,2016-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2776217.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q2,2016-01-01,2016-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-14747835.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q2,2016-01-01,2016-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-14747835.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q2,2016-01-01,2016-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-94022.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q2,2016-01-01,2016-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,3200000.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q2,2016-01-01,2016-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,3105978.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q2,2016-01-01,2016-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,3105978.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q2,2016-01-01,2016-03-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-54275.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q2,2016-01-01,2016-03-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,25544.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q2,2016-01-01,2016-03-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-193653.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q2,2016-01-01,2016-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-222384.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q2,2016-01-01,2016-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-222384.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q2,2016-01-01,2016-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-11864241.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q2,2016-01-01,2016-03-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,2743.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q2,2016-01-01,2016-03-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,2400.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q3,2016-04-01,2016-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-19420742.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q3,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-19420742.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q3,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,818200.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q3,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-179460.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q3,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2952131.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q3,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2520332.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q3,2016-04-01,2016-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-18350203.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q3,2016-04-01,2016-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-18350203.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q3,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-647114.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q3,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,10108000.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q3,2016-04-01,2016-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,9460886.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q3,2016-04-01,2016-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,9460886.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q3,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-54498.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q3,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-25544.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q3,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,2285055.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q3,2016-04-01,2016-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2205013.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q3,2016-04-01,2016-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2205013.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q3,2016-04-01,2016-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-6684304.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q3,2016-04-01,2016-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,3109.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q4,2016-07-01,2016-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-22221986.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q4,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-22221986.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q4,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,843584.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q4,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,6129222.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q4,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,5067801.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q4,2016-07-01,2016-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-10181379.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q4,2016-07-01,2016-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-10181379.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q4,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2712489.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q4,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1000000.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q4,2016-07-01,2016-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1712489.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q4,2016-07-01,2016-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1712489.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q4,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-54725.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q4,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,52231433.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q4,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1467065.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q4,2016-07-01,2016-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,53643773.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q4,2016-07-01,2016-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,53643773.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q4,2016-07-01,2016-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,41749905.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q4,2016-07-01,2016-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,2381.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q1,2016-10-01,2016-12-31,2018-02-09 16:11:50+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12086108.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q1,2016-10-01,2016-12-31,2018-02-09 16:11:50+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12086108.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q1,2016-10-01,2016-12-31,2018-02-09 16:11:50+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1185611.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q1,2016-10-01,2016-12-31,2018-02-09 16:11:50+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2424442.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q1,2016-10-01,2016-12-31,2018-02-09 16:11:50+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,18476246.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q1,2016-10-01,2016-12-31,2018-02-09 16:11:50+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,10000191.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q1,2016-10-01,2016-12-31,2018-02-09 16:11:50+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,10000191.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q1,2016-10-01,2016-12-31,2018-02-09 16:11:50+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-5296653.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q1,2016-10-01,2016-12-31,2018-02-09 16:11:50+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-5296653.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q1,2016-10-01,2016-12-31,2018-02-09 16:11:50+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-5296653.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q1,2016-10-01,2016-12-31,2018-02-09 16:11:50+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-47277.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q1,2016-10-01,2016-12-31,2018-02-09 16:11:50+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,12500000.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q1,2016-10-01,2016-12-31,2018-02-09 16:11:50+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-417140.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q1,2016-10-01,2016-12-31,2018-02-09 16:11:50+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,12035583.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q1,2016-10-01,2016-12-31,2018-02-09 16:11:50+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,12035583.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q1,2016-10-01,2016-12-31,2018-02-09 16:11:50+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,16739121.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q1,2016-10-01,2016-12-31,2018-02-09 16:11:50+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,48195.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q2,2017-01-01,2017-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6042559.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q2,2017-01-01,2017-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6042559.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q2,2017-01-01,2017-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1187644.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q2,2017-01-01,2017-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1679844.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q2,2017-01-01,2017-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-11150986.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q2,2017-01-01,2017-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-14326057.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q2,2017-01-01,2017-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-14326057.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q2,2017-01-01,2017-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1356505.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q2,2017-01-01,2017-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-24846105.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q2,2017-01-01,2017-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-26202610.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q2,2017-01-01,2017-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-26202610.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q2,2017-01-01,2017-03-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-49868.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q2,2017-01-01,2017-03-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,191937.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q2,2017-01-01,2017-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,142069.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q2,2017-01-01,2017-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,142069.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q2,2017-01-01,2017-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-40386598.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q2,2017-01-01,2017-03-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,47349.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q2,2017-01-01,2017-03-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,2400.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q4,2017-07-01,2017-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10731886.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q4,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10731886.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q4,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1154525.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q4,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2106216.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q4,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1732329.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q4,2017-07-01,2017-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-9203474.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q4,2017-07-01,2017-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-9203474.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q4,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-107444.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q4,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-5070060.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q4,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,958753.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q4,2017-07-01,2017-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-4218751.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q4,2017-07-01,2017-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-4218751.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q4,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-100645.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q4,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-21698.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q4,2017-07-01,2017-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-122343.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q4,2017-07-01,2017-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-122343.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q4,2017-07-01,2017-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-13544568.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q4,2017-07-01,2017-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,45614.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q1,2017-10-01,2017-12-31,2019-02-07 16:50:40+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-13198878.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q1,2017-10-01,2017-12-31,2019-02-07 16:50:40+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-13198878.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q1,2017-10-01,2017-12-31,2019-02-07 16:50:40+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1141173.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q1,2017-10-01,2017-12-31,2019-02-07 16:50:40+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2200324.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q1,2017-10-01,2017-12-31,2019-02-07 16:50:40+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-4833099.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q1,2017-10-01,2017-12-31,2019-02-07 16:50:40+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-14690480.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q1,2017-10-01,2017-12-31,2019-02-07 16:50:40+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-14690480.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q1,2017-10-01,2017-12-31,2019-02-07 16:50:40+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-135414.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q1,2017-10-01,2017-12-31,2019-02-07 16:50:40+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-5018040.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q1,2017-10-01,2017-12-31,2019-02-07 16:50:40+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,6510420.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q1,2017-10-01,2017-12-31,2019-02-07 16:50:40+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,1356966.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q1,2017-10-01,2017-12-31,2019-02-07 16:50:40+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,1356966.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q1,2017-10-01,2017-12-31,2019-02-07 16:50:40+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-197790.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q1,2017-10-01,2017-12-31,2019-02-07 16:50:40+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,224082.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q1,2017-10-01,2017-12-31,2019-02-07 16:50:40+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,26292.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q1,2017-10-01,2017-12-31,2019-02-07 16:50:40+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,26292.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q1,2017-10-01,2017-12-31,2019-02-07 16:50:40+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-13307222.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q1,2017-10-01,2017-12-31,2019-02-07 16:50:40+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,44722.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q2,2018-01-01,2018-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14884311.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q2,2018-01-01,2018-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14884311.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q2,2018-01-01,2018-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1153466.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q2,2018-01-01,2018-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1695369.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q2,2018-01-01,2018-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-3407978.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q2,2018-01-01,2018-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-15443454.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q2,2018-01-01,2018-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-15443454.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q2,2018-01-01,2018-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-378305.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q2,2018-01-01,2018-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,17194000.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q2,2018-01-01,2018-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,16815695.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q2,2018-01-01,2018-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,16815695.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q2,2018-01-01,2018-03-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,95384.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q2,2018-01-01,2018-03-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,56585035.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q2,2018-01-01,2018-03-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,221112.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q2,2018-01-01,2018-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,56901531.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q2,2018-01-01,2018-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,56901531.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q2,2018-01-01,2018-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,58273772.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q2,2018-01-01,2018-03-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,43815.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q2,2018-01-01,2018-03-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,2400.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q3,2018-04-01,2018-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-15606018.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q3,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-15606018.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q3,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1176241.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q3,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2504799.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q3,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2484187.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q3,2018-04-01,2018-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-14409165.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q3,2018-04-01,2018-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-14409165.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q3,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-198060.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q3,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-42156580.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q3,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,13500000.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q3,2018-04-01,2018-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-28854640.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q3,2018-04-01,2018-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-28854640.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q3,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-52580.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q3,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1506654.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q3,2018-04-01,2018-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1454074.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q3,2018-04-01,2018-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1454074.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q3,2018-04-01,2018-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-41809731.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q3,2018-04-01,2018-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,42892.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q1,2018-10-01,2018-12-31,2020-02-05 16:11:49+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,12037253.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q1,2018-10-01,2018-12-31,2020-02-05 16:11:49+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,12037253.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q1,2018-10-01,2018-12-31,2020-02-05 16:11:49+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1177352.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q1,2018-10-01,2018-12-31,2020-02-05 16:11:49+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-156637.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q1,2018-10-01,2018-12-31,2020-02-05 16:11:49+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2717534.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q1,2018-10-01,2018-12-31,2020-02-05 16:11:49+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,152509261.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q1,2018-10-01,2018-12-31,2020-02-05 16:11:49+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,168284763.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q1,2018-10-01,2018-12-31,2020-02-05 16:11:49+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,168284763.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q1,2018-10-01,2018-12-31,2020-02-05 16:11:49+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-737487.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q1,2018-10-01,2018-12-31,2020-02-05 16:11:49+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-69271001.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q1,2018-10-01,2018-12-31,2020-02-05 16:11:49+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,2252219.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q1,2018-10-01,2018-12-31,2020-02-05 16:11:49+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-67756269.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q1,2018-10-01,2018-12-31,2020-02-05 16:11:49+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-67756269.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q1,2018-10-01,2018-12-31,2020-02-05 16:11:49+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-2415149.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q1,2018-10-01,2018-12-31,2020-02-05 16:11:49+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,60521729.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q1,2018-10-01,2018-12-31,2020-02-05 16:11:49+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1004694.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q1,2018-10-01,2018-12-31,2020-02-05 16:11:49+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,59111274.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q1,2018-10-01,2018-12-31,2020-02-05 16:11:49+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,59111274.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q1,2018-10-01,2018-12-31,2020-02-05 16:11:49+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,159639768.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q1,2018-10-01,2018-12-31,2020-02-05 16:11:49+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,27437.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q2,2019-01-01,2019-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,23896982.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q2,2019-01-01,2019-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,23896982.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q2,2019-01-01,2019-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1175967.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q2,2019-01-01,2019-03-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,486866.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q2,2019-01-01,2019-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2601348.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q2,2019-01-01,2019-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-47747671.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q2,2019-01-01,2019-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-19586508.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q2,2019-01-01,2019-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-19586508.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q2,2019-01-01,2019-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-209301.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q2,2019-01-01,2019-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-20995000.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q2,2019-01-01,2019-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,9987000.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q2,2019-01-01,2019-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-11217301.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q2,2019-01-01,2019-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-11217301.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q2,2019-01-01,2019-03-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q2,2019-01-01,2019-03-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,2670037.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q2,2019-01-01,2019-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2670036.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q2,2019-01-01,2019-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2670036.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q2,2019-01-01,2019-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-28133773.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q2,2019-01-01,2019-03-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,2400.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q3,2019-04-01,2019-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,20335709.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q3,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,20335709.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q3,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1003450.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q3,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-330229.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q3,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2640236.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q3,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-13122404.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q3,2019-04-01,2019-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,10526762.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q3,2019-04-01,2019-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,10526762.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q3,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-3223497.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q3,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,17622000.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q3,2019-04-01,2019-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,14398503.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q3,2019-04-01,2019-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,14398503.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q3,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,2767274.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q3,2019-04-01,2019-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2767274.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q3,2019-04-01,2019-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2767274.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q3,2019-04-01,2019-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,27692539.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q4,2019-07-01,2019-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,11704905.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q4,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,11704905.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q4,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1082375.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q4,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5503275.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q4,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-4480649.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q4,2019-07-01,2019-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,13809906.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q4,2019-07-01,2019-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,13809906.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q4,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-7830940.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q4,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,24660000.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q4,2019-07-01,2019-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,16829060.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q4,2019-07-01,2019-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,16829060.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q4,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,10.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q4,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1833405.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q4,2019-07-01,2019-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1833415.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q4,2019-07-01,2019-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1833415.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q4,2019-07-01,2019-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,32472381.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q4,2019-07-01,2019-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,300000.0
